CHARLOTTE, N.C., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that it has priced an underwritten public offering of 4,338,500 shares of its common stock at a price of $4.75 per share. Net proceeds after underwriting discounts and commissions and expenses will be approximately $19.2 million. The company also has granted the underwriters a 30-day option to purchase up to an additional 650,775 shares to cover over-allotments, if any, which would result in additional net proceeds of approximately $2.9 million, if exercised in full. The offering is expected to close on or about January 11, 2012, subject to satisfaction of customary closing conditions.
